DCF Advisers, LLC - Q4 2022 holdings

$148 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 66.7% .

 Value Shares↓ Weighting
SPY BuySPDR S&P 500 ETF TRput$12,046,545
+64.5%
31,500
+53.7%
8.14%
+72.1%
BAC BuyBK OF AMERICA CORP$7,948,800
+75.5%
240,000
+60.0%
5.37%
+83.5%
GOOG BuyALPHABET INCcap stk cl c$7,275,860
-5.4%
82,000
+2.5%
4.92%
-1.1%
PRTA BuyPROTHENA CORP PLC$4,464,525
+8.3%
74,100
+9.0%
3.02%
+13.3%
ET BuyENERGY TRANSFER L P$4,362,225
+9.9%
367,500
+2.1%
2.95%
+14.9%
GLD BuySPDR GOLD TR$4,071,360
+17.0%
24,000
+6.7%
2.75%
+22.4%
ORCL BuyORACLE CORP$3,514,820
+47.6%
43,000
+10.3%
2.38%
+54.3%
ALT BuyALTIMMUNE INCcall$2,451,050
+754.0%
149,000
+562.2%
1.66%
+795.1%
VOO NewVANGUARD INDEX FDSput$1,756,7005,000
+100.0%
1.19%
GDXJ NewVANECK ETF TRUSTjunior gold mine$1,604,25045,000
+100.0%
1.08%
SGEN BuySEAGEN INC$1,599,950
-0.5%
12,450
+6.0%
1.08%
+4.0%
JQC BuyNUVEEN CR STRATEGIES INCOME$1,585,128
+97.6%
311,420
+98.4%
1.07%
+106.8%
SLV BuyISHARES SILVER TRishares$1,310,190
+49.7%
59,500
+19.0%
0.88%
+56.6%
SHY NewISHARES TRput$933,45511,500
+100.0%
0.63%
SNY BuySANOFIsponsored adr$702,235
+67.6%
14,500
+31.7%
0.48%
+75.3%
VIR NewVIR BIOTECHNOLOGY INC$607,44024,000
+100.0%
0.41%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$572,5856,500
+100.0%
0.39%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDcall$558,675
+62.9%
7,500
+50.0%
0.38%
+70.3%
PAAS NewPAN AMERN SILVER CORP$531,05032,500
+100.0%
0.36%
GOLD BuyBARRICK GOLD CORP$515,400
+232.5%
30,000
+200.0%
0.35%
+248.0%
NewTURNING PT BRANDS INC2.500% 7/1$439,485500,000
+100.0%
0.30%
BUR BuyBURFORD CAP LTDcall$370,010
+26.3%
45,400
+16.4%
0.25%
+32.3%
XBI NewSPDR SER TRs&p biotech$290,5003,500
+100.0%
0.20%
BUR BuyBURFORD CAP LTD$285,250
+46.3%
35,000
+34.6%
0.19%
+53.2%
TGNA NewTEGNA INC$264,87512,500
+100.0%
0.18%
EQ BuyEQUILLIUM INC$262,416
-49.4%
247,562
+5.9%
0.18%
-47.2%
XLE NewSELECT SECTOR SPDR TRput$218,6752,500
+100.0%
0.15%
BuyESPERION THERAPEUTICS INC NEnote 4.000%11/1$198,900
-77.5%
3,600,000
+132.3%
0.13%
-76.5%
PAAS NewPAN AMERN SILVER CORPcall$163,40010,000
+100.0%
0.11%
AMRN NewAMARIN CORP PLCspons adr new$24,20020,000
+100.0%
0.02%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTRA-CELLULAR THERAPIES INC16Q3 202310.2%
MICRON TECHNOLOGY INC16Q3 20236.7%
ALPHABET INC16Q3 20235.8%
ABBVIE INC16Q3 20237.9%
REGENERON PHARMACEUTICALS16Q3 20235.5%
ARGENX SE16Q3 20236.4%
SPDR GOLD TRUST16Q3 20236.6%
XENCOR INC16Q3 20234.1%
BK OF AMERICA CORP16Q3 20235.4%
ORACLE CORP16Q3 20233.2%

View DCF Advisers, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-09
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View DCF Advisers, LLC's complete filings history.

Compare quarters

Export DCF Advisers, LLC's holdings